Results 81 to 90 of about 669,720 (312)

Characteristics Of R718 Thermocompression Refrigerating / Heat Pump Systems With Two-Phase Ejectors

open access: yes, 2012
The paper describes the investigations of the R718 thermocompression refrigerating cycle with two-phase ejector as a compression device. The complex thermal and flow phenomena connected with compression and condensation inside the two-phase ejector flow ...
Sarevski, Vasko Nikola   +1 more
core  

Phase-based approaches for treating complex trauma: a critical evaluation and case for implementation in the Australian context

open access: yes, 2021
Phase-based approaches are a recommended treatment option for individuals with complex trauma histories; however, this is based on a limited body of empirical evidence.
Jessica L. Mackelprang (11399756)   +5 more
core   +1 more source

Clinical performance of the urine‐based TERT promoter AbsoluteQ Digital PCR for non‐invasive detection of bladder cancer

open access: yesMolecular Oncology, EarlyView.
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel   +12 more
wiley   +1 more source

Preliminary Study of a Novel Compact R718 Water Chiller With Integration of a Single Stage Centrifugal Compressor and Two-Phase Ejectors

open access: yes, 2012
A novel compact R718 water chiller with integration of a centrifugal compressor stage and two phase ejectors as a second stage compression device is proposed. The paper describes the investigations of this R718 refrigerating cycle. The limitations of the
Sarevski, Vasko Nikola   +1 more
core  

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Connecting the Dots: Case Studies and EU Implementation Research [PDF]

open access: yes
This paper is an accompanying text to the Compliance Database – the database of case studies of transposition, implementation, and compliance with EU law. (stract http://www.eif.oeaw.ac.at/compliance/).
Moritz Knoll   +2 more
core  

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

open access: yesMolecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens   +6 more
wiley   +1 more source

District plan implementation under the RMA: Confessions of a resource consent

open access: yes, 2003
This report focuses on results from Phase 2 of PUCM - the quality of plan implementation in six district councils selected for their range of plan quality and capacity to plan.
Barfoot, Cushla   +13 more
core  

Implementation Science and Employer Disability Practices: Embedding Implementation Factors in Research Designs [PDF]

open access: yes, 2016
Purpose For work disability research to have an impact on employer policies and practices it is important for such research to acknowledge and incorporate relevant aspects of the workplace.
Main, Caitlin
core   +1 more source

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

open access: yesMolecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy